Skip to main content
Company Offering
SEC Accession #

0001670254-21-000500

Platform Raised on
Filing Date
Deadline Date

Investment Security Details

Submission
Offering Statement
Nature of Ammendment
Updated officers, voting power, risks, cap table, past raises, and financial condition. Added CPA reviewed financial statements for 2020 and a Lead Investor, Clarified that New Series Preferred Stock would be junior in liquidation preference.
Price of Security
$1.00
Round
Simple Agreement for Future Equity (SAFE)
# Securities
50,000
Capital Type

Other

Max Offering
$1,070,000.00
Price Detail
Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.

Investing Platform Detail

Platform Comp
7.5% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Financial Interest
No

Offering Company Details

Executive Signatory
Lawrence Margolis
Title
Founder/CEO
Website
https://www.personalrx.com/
Employee Count at Offering
20
SEC CIK
1826196
FILE NUMBER
020-27103

Comments